266 related articles for article (PubMed ID: 20732354)
1. The development of MDA-7/IL-24 as a cancer therapeutic.
Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Wang XY; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak MS; Grant S; Curiel DT; Fisher PB
Pharmacol Ther; 2010 Nov; 128(2):375-84. PubMed ID: 20732354
[TBL] [Abstract][Full Text] [Related]
2. MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.
Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak M; Grant S; Curiel DT; Fisher PB
Anticancer Drugs; 2010 Sep; 21(8):725-31. PubMed ID: 20613485
[TBL] [Abstract][Full Text] [Related]
3. MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?
Dent P; Yacoub A; Grant S; Curiel DT; Fisher PB
J Cell Biochem; 2005 Jul; 95(4):712-9. PubMed ID: 15880678
[TBL] [Abstract][Full Text] [Related]
4. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.
Gupta P; Su ZZ; Lebedeva IV; Sarkar D; Sauane M; Emdad L; Bachelor MA; Grant S; Curiel DT; Dent P; Fisher PB
Pharmacol Ther; 2006 Sep; 111(3):596-628. PubMed ID: 16464504
[TBL] [Abstract][Full Text] [Related]
5. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
Lebedeva IV; Emdad L; Su ZZ; Gupta P; Sauane M; Sarkar D; Staudt MR; Liu SJ; Taher MM; Xiao R; Barral P; Lee SG; Wang D; Vozhilla N; Park ES; Chatman L; Boukerche H; Ramesh R; Inoue S; Chada S; Li R; De Pass AL; Mahasreshti PJ; Dmitriev IP; Curiel DT; Yacoub A; Grant S; Dent P; Senzer N; Nemunaitis JJ; Fisher PB
Int J Oncol; 2007 Nov; 31(5):985-1007. PubMed ID: 17912425
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
Emdad L; Bhoopathi P; Talukdar S; Pradhan AK; Sarkar D; Wang XY; Das SK; Fisher PB
Semin Cancer Biol; 2020 Nov; 66():140-154. PubMed ID: 31356866
[TBL] [Abstract][Full Text] [Related]
7. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
Fisher PB; Gopalkrishnan RV; Chada S; Ramesh R; Grimm EA; Rosenfeld MR; Curiel DT; Dent P
Cancer Biol Ther; 2003; 2(4 Suppl 1):S23-37. PubMed ID: 14508078
[TBL] [Abstract][Full Text] [Related]
8. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.
Fisher PB; Sarkar D; Lebedeva IV; Emdad L; Gupta P; Sauane M; Su ZZ; Grant S; Dent P; Curiel DT; Senzer N; Nemunaitis J
Toxicol Appl Pharmacol; 2007 Nov; 224(3):300-7. PubMed ID: 17208263
[TBL] [Abstract][Full Text] [Related]
9. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.
Emdad L; Lebedeva IV; Su ZZ; Gupta P; Sauane M; Dash R; Grant S; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Biol Ther; 2009 Mar; 8(5):391-400. PubMed ID: 19276652
[TBL] [Abstract][Full Text] [Related]
10. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.
Sauane M; Gopalkrishnan RV; Sarkar D; Su ZZ; Lebedeva IV; Dent P; Pestka S; Fisher PB
Cytokine Growth Factor Rev; 2003 Feb; 14(1):35-51. PubMed ID: 12485618
[TBL] [Abstract][Full Text] [Related]
11. mda-7 (IL-24): signaling and functional roles.
Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Dent P; Fisher PB
Biotechniques; 2002 Oct; Suppl():30-9. PubMed ID: 12395925
[TBL] [Abstract][Full Text] [Related]
12. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.
Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Valerie K; Dent P; Fisher PB
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10054-9. PubMed ID: 12114539
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
Tong AW; Nemunaitis J; Su D; Zhang Y; Cunningham C; Senzer N; Netto G; Rich D; Mhashilkar A; Parker K; Coffee K; Ramesh R; Ekmekcioglu S; Grimm EA; van Wart Hood J; Merritt J; Chada S
Mol Ther; 2005 Jan; 11(1):160-72. PubMed ID: 15585417
[TBL] [Abstract][Full Text] [Related]
14. Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells.
Hamed HA; Das SK; Sokhi UK; Park MA; Cruickshanks N; Archer K; Ogretmen B; Grant S; Sarkar D; Fisher PB; Dent P
Cancer Biol Ther; 2013 Nov; 14(11):1039-49. PubMed ID: 24025359
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
Yacoub A; Liu R; Park MA; Hamed HA; Dash R; Schramm DN; Sarkar D; Dimitriev IP; Bell JK; Grant S; Farrell NP; Curiel DT; Fisher PB; Dent P
Mol Pharmacol; 2010 Feb; 77(2):298-310. PubMed ID: 19910452
[TBL] [Abstract][Full Text] [Related]
16. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus.
Sarkar S; Azab B; Quinn BA; Shen X; Dent P; Klibanov AL; Emdad L; Das SK; Sarkar D; Fisher PB
Curr Mol Med; 2014 Jan; 14(1):125-40. PubMed ID: 24236457
[TBL] [Abstract][Full Text] [Related]
18. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
19. Targeted combinatorial therapy of non-small cell lung carcinoma using a GST-fusion protein of full-length or truncated MDA-7/IL-24 with Tarceva.
Gupta P; Emdad L; Lebedeva IV; Sarkar D; Dent P; Curiel DT; Settleman J; Fisher PB
J Cell Physiol; 2008 Jun; 215(3):827-36. PubMed ID: 18270968
[TBL] [Abstract][Full Text] [Related]
20. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
